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Abstract: Introduction: Considering the existing contradictions regarding effectiveness of intravenous (IV) lidocaine, es-
pecially in emergency department (ED), the present study was designed to compare the analgesic effect of IV
lidocaine and morphine sulfate in pain management for extremity bone fractures. Methods: In this triple blind
clinical trial, 15 to 65 year-old patients with extremity fractures and in need of pain management were randomly
allocated to either IV lidocaine or morphine sulfate group and were compared regarding severity of pain 5, 10,
15, 20, 25, and 30 minutes after infusion via intention to treat analysis. The absolute risk reduction, number
needed to treat and relative risk of IV lidocaine after 30 minutes were 0.40 (95%CI: 0.25 – 0.64), 7 (95%CI: 3.7 –
23.1), and 20.71 (95%CI: 10.91 – 30.51), respectively. Results: 280 patients with the mean age of 32.50 ± 12.77
years were randomly divided into 2 equal groups of 140 (73.9% male). The 2 groups had similar baseline char-
acteristics. 15 minutes success rate was 49.28% in lidocaine and 33.57% in morphine sulfate group (p = 0.011),
and after 30 minutes it reached to 85.71% and 65.00%, respectively (p < 0.001). Conclusion: Based on the results
of the present study, IV lidocaine could be considered as a reasonable alternative choice for pain management
in ED.
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1. Introduction
P
ain is an unpleasant mental and sensory experience
that often occurs after a tissue injury and secretion of
inflammatory cytokines (1). Various methods, such
as using opioids and non-steroid anti-inflammatory drugs,
topical anesthetics and regional nerve block are applied for
pain management (2-6). Intravenous (IV) infusion of lido-
caine is one of the methods used by anesthesiology special-
ists for induction of analgesia (7-11). Lidocaine is a relatively
safe drug in the amide group, which acts as an analgesic,
anti-hyperalgesia and anti-inflammatory agent in low doses
and is affective in relieving neuralgia, burn and procedural
pains (12). This drug induces its analgesic effects via stimu-
lating secretion of anti-inflammatory cytokines (interleukin-
1) receptor antagonist and blocking central and peripheral
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voltage-dependent sodium channels (13). In cases that opi-
oids lack efficient effectiveness, IV injection of lidocaine has
been used as a proper replacement (12, 14, 15). Although
many studies have indicated the role of IV lidocaine in pain
relief after trauma or surgery and decrease in the need for
other opioids, there are also studies that do not agree (7). For
example, in one study continuous infusion of low doses of li-
docaine, had not reduced use of other analgesics (16). In ad-
dition, for induction of analgesia after tonsillectomy surgery,
infusion of IV lidocaine did not play an effective role in re-
ducing pain after surgery (17). Therefore, considering the
limited number of studies on the effect of IV lidocaine in
pain management, especially in emergency department (ED)
and the existing contradictions regarding its effectiveness,
the present study was designed with the aim of assessing the
analgesic effect of IV lidocaine compared to IV morphine sul-
fate in relieving the pain caused by traumatic extremity bone
fractures.
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2. Methods
2.1. Study design
The present clinical trial was carried out during a 6 month
period from June 2016 to Nov 2016 on patients presenting to
ED of Imam Khomeini and Golestan Hospitals in Ahvaz, Iran,
who needed pain management due to traumatic bone frac-
tures. Before including the patients in the study, informed
consent was obtained from them and they were given expla-
nations regarding the study process. Throughout all steps
of the study, the researchers adhered to the principles of
Helsinki Declaration and confidentiality of patient data. All
costs of the project were covered by the researchers and no
additional costs were inflicted on the patients. This study
was approved by the ethics committee of Ahvaz University of
medical sciences and has been registered on Iranian registry
of clinical trials under the number IRCT2015052622423N1.
2.2. Participants
The study population consisted of patients aged 15 to 65
years who had fractures in the long bones of their upper
or lower extremities and the fracture was evident in physi-
cal examination and the patient needed pain management
(moderate to severe pain). Pregnant and lactating women;
patients with altered level of consciousness; hemodynamic
instability; evidence of intra-abdominal or pelvic hemor-
rhage; mental retardation; history of allergy to lidocaine or
morphine; history of addiction; underlying illness (coronary
artery problems, valvular disorders, arrhythmia, hyperten-
sion, cerebrovascular diseases, seizure, diabetes, liver or kid-
ney diseases); and consuming cardiac drugs were excluded
from the study. No limitations were considered regarding sex
and fracture type and being open or closed fracture. Physi-
cal examination and patient selection was done by a senior
emergency medicine resident and a senior orthopedics resi-
dent.
2.3. Intervention
After selecting the patients that met the inclusion criteria of
the study, they were divided into 2 groups receiving either IV
lidocaine (1.5 mg/kg during 2 minutes) or IV morphine sul-
fate (0.1 mg/kg during 2 minutes). The study was designed as
a triple blind manner as the patient, the person injecting the
drug, and data analyzer were all blind to the type of drug con-
sumed. Both drugs were colorless and odorless and to make
them look alike, both drugs were injected in a 10cc volume
with syringes with the same shape and color. Injection was
performed by either an emergency medicine specialist or a
senior resident of emergency medicine under complete car-
diac, respiratory, blood pressure, level of consciousness and
pulse oximetry monitoring. Before the injection of drug, vital
signs of the patient and their pain score using visual analog
scale (VAS) were measured and recorded.
2.4. Data gathering
A checklist consisting of demographic data (age, sex), vital
signs (number of breaths per minute, systolic and diastolic
blood pressures, heart beats per minute, and oxygen satu-
ration percentage) and pain severity on presentation and 5,
10, 15, 20, 25, and 30 minutes after injection was filled for
all the patients. The senior emergency medicine resident in
charge of the patient was responsible for gathering the data,
but evaluation of vital signs of the patient was performed by
someone other than the one injecting the drugs, who was
blind to the type of drug used. To measure pain severity, VAS
scale was used. Pain score of 3 to 6 was considered as moder-
ate pain and score ≥6 was considered as severe pain. At least
3 points drop in pain score was considered as success in pain
management. If pain was still present after 30 minutes, IV
fentanyl with 1.5 mg/kg dose was prescribed for the patients
as bolus.
2.5. Outcome
At least 3 scores drop in pain severity was considered as suc-
cess and less than 3 scores as failure in treatment on 15th and
30th minutes. In addition, patients were assessed regarding
manifestation of any side effects such as confusion; tremor;
stupor; seizure; restlessness; anxiety; lethargy; sleepiness;
hallucination; strabismus; syncope; hypotension; bradycar-
dia; cardiac failure; new arrhythmia; cardiac failure; anaphy-
laxis; status asthmaticus; edema; nausea; vomiting; rash and
tinnitus. It was determined that in case of any drug side ef-
fects, the patient should be excluded from the study and be
rapidly treated for relieving the side effect.
2.6. Statistical analysis
Non-probability convenience sampling was used and analy-
sis of data was done with intention to treat method via SPSS
21 statistical software. Quantitative variables were reported
as mean ± standard deviation (SD), and qualitative data as
frequency and percentage. To report the effectiveness of the
drug, absolute risk reduction (ARR), number needed to treat
(NNT) and relative risk (RR) were used with 95% CI. To do
comparisons between the 2 groups, chi square and t-test
were used. P < 0.05 was considered as level of significance.
3. Results
280 patients with the mean age of 32.50 ± 12.77 years (15 -
65) were randomly divided into 2 equal groups receiving ei-
ther IV lidocaine (140 patients) or morphine sulfate (140 pa-
tients) (73.9% male). Table 1 compares baseline data of the
participants in the 2 groups. The 2 groups had similar char-
acteristics regarding pain severity and vital signs on admis-
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Table 1: Comparison of baseline patients’ data in the 2 study groups on admission to emergency department
Variable Groups P value
IV* lidocaine IV* morphine
Age (year) 31.47 ± 12.31 33.53 ± 13.16 0.178
Sex
Male 104 (50.2) 103 (49.8) 0.500
Female 36 (49.3) 37 (50.7)
Pain severity
Moderate 12 (8.6) 17 (12.1) 0.434
Severe 128 (91.4) 123 (87.9)
Heart rate (per minute) 89.06 ± 6.98 88.19 ± 8.98 0.328
Respiratory rate (per minute) 17.93 ± 1.69 18.30 ± 1.81 0.078
Systolic blood pressure (mmHg) 123.85 ± 11.68 124.5 ± 13.46 0.667
Diastolic blood pressure (mmHg) 76.21 ± 6.90 77.26 ± 9.09 0.281
Oxygen saturation (%) 98.46 ± 0.76 98.36 ± 0.71 0.293
∗IV: intravenous;
Data are presented as frequency and percentage or mean ± standard deviation. Pain severity is shown based on VAS score.
Table 2: Comparing the pain severity of the patients between the 2 studied groups in the initial 30 minutes after intravenous (IV) injection of
the drug
Pain severity Study groups; no (%) P value
IV lidocaine IV morphine
15 minutes
Mild 10 (7.1) 10 (7.1)
Moderate 70 (50.0) 66 (47.1) 0.884
Severe 60 (42.9) 64 (45.8)
30 minutes
Mild 51 (36.4) 37 (27.1)
Moderate 58 (41.5) 61 (43.6) 0.186
Severe 31 (22.1) 41 (29.3)
Table 3: Effectiveness characteristics of intravenous lidocaine in pain management of patients with extremity fractures
Characteristics Values (95% CI)
After 15 minutes After 30 minutes
MS failure rate 66.43% 35.00%
Lidocaine failure rate 50.71% 14.29%
Relative risk 0.76 (0.62 – 0.93) 0.40 (0.25 – 0.64)
Absolute risk reduction 15.72 (4.33 – 27.11) 20.71 (10.91 – 30.51)
Number needed to treat 5 (3.3 – 9.2) 7 (3.7 – 23.1)
MS: morphine sulfate
sion to ED. Table 2 and figure 1 depict the rate of decrease in
pain severity in the 2 studied groups at various times after IV
injection. Success rate in decreasing pain severity (at least 3
points) 15 minutes after injection was 49.28% (69 individuals)
in lidocaine group and 33.57% (47 patients) in morphine sul-
fate group (p = 0.011), and 30 minutes after injection, these
numbers were 85.71% (120 patients) and 65.00% (91 individ-
uals), respectively (p < 0.001). No cases of hypotension, res-
piratory depression, dysrhythmia and drop in arterial oxygen
saturation were detected in either group during the initial 30
minutes after drug injection.
4. Discussion
Based on the results of the present study, success rate of IV li-
docaine in relieving the pain caused by extremity fractures
was significantly higher than that of morphine sulfate, 15
and 30 minutes after injection. Other indices of effectiveness
such as RR, ARR and NNT also confirmed the proper effect of
IV lidocaine for management of acute pain. In addition, no
drug side effect was detected in either group. While about
half of the patients who received IV lidocaine experienced
at least 3 points drop in their pain score during the first 15
minutes after injection, this rate was 33% for the group re-
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Figure 1: Changes in pain severity measures in the 2 studied groups
at different times after intravenous injection of the drug.
ceiving IV morphine. In other words, using lidocaine led to
15% to 20% drop in unsuccessful pain management cases 15
and 30 minutes after injection. Relative risk or risk ratio of
using lidocaine 15 and 30 minutes after injection were 0.40
and 0.76, respectively. In other words, the probability of not
controlling the pain in lidocaine group relative to morphine
sulfate group was less than 1, which confirms its higher ef-
fectiveness. Numerous studies have confirmed the effective-
ness of IV lidocaine for successful pain management and its
role in decreasing the need for opioid use (12, 14, 15). Low
dose of IV lidocaine has been safer and more effective than
regional analgesia in relieving pain caused by forearm frac-
ture in children (18). A clinical trial by El-Tahan et al. in
2009 showed that IV lidocaine prescription before cesarean
section surgery leads to less increase in heart rate, average
arterial pressure and concentration of plasma cortisol. Their
findings indicated that IV lidocaine can be considered as a
safe and effective choice for reducing stress response of the
mother to surgery during cesarean delivery (19). Findings
of Yardeni et al. in 2009 showed that injection of IV lido-
caine before and during surgery can be effective in improve-
ment of pain management after surgery as well as reduction
of immune interference and release of pain and inflamma-
tion inducing mediators due to surgery (20). Need for mor-
phine sulfate in the first 72 hours post operation was lower in
the group that had received IV lidocaine before surgery (21).
Based on the findings of the present study, it seems that IV
lidocaine has proper effectiveness in controlling acute pain
caused by extremity fractures. Probably, the main reason for
the low rate of using this option for pain management in ED
is fear of side effects such as dysrhythmia. It seems that since
most of the patients participating in the present study were
either young or in their midlife, the probability of showing
cardiac side effects was naturally lower. It seems more logical
to decide on the side effects of injecting the drug after studies
on various age groups and considering their various underly-
ing illnesses. If the results of the present study are confirmed
in other studies, we can count on IV lidocaine as an option
and proper replacement for pain management of patients in
ED.
5. Limitation
Longer follow up of the patients and calculating the patients’
need for using analgesics after probable relapses are among
the points that can decrease the limitations of the present
study. Measuring serum level of lidocaine to avoid reach-
ing toxic levels of the drug can also be considered in future
studies. Repeating the study in populations with various age
ranges and considering various types of underlying illnesses
can be beneficial. In addition, for a more accurate compar-
ison, fracture types and their location should better be ho-
mogenized between the 2 groups. However, random alloca-
tion of the patients prevented this confounding factor affect-
ing the results to a great extent in the current study.
6. Conclusion
Based on the results of the present study, success rate of IV
lidocaine in relieving pain caused by extremity fracture was
significantly higher than IV morphine. Using lidocaine led to
20% decrease in unsuccessful pain management cases until
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